Quote | Super Quote
Future News

24/09/2026 13:30

Biotech stocks broadly sold off, sector sees outflow of over HK$840 million; Genscript Biotech down over 4%, XTAL Biotech drops nearly 10%

   Genscript Biotech (01548) is down 4.6%, trading at HK$39.82, with approximately 19.14 million shares traded, involving a turnover of HK$780 million.

  After the meeting between Xi and Trump, China and the U.S. announced only an extension of their trade truce until January 10 next year. However, U.S. Treasury Secretary Bessent did not clarify whether the two sides would reach a broader agreement, causing market concerns that the trade war might continue beyond the new deadline. Additionally, strong U.S. PMI data for September boosted expectations of interest rate hikes, with the market estimating over a 70% chance of a rate hike by the end of October. The yield on the U.S. 10-year Treasury bond surged past 5.1%.

  With no significant positive outcomes from the Xi-Trump meeting and rising bond yields negatively impacting biotech firms' financing, the biotech sector came under pressure this morning. The healthcare sector has recorded net active selling of over HK$845 million, making it the sector with the largest net outflow. Biotech stocks declined collectively: Genscript Biotech (01548) fell 4.6% to HK$39.82; WuXi Biologics (02269) dropped 1.6% to HK$51.95; Insilico Medicine (03696) declined 3.8% to HK$56.45; XtalPi Holdings (02228) fell 2.9% to HK$8.145; XTAL Biotech-P (07666) plunged 9.7% to HK$15.7; Innovent Biologics (01801) dropped 3% to HK$100.3; and Akeso (09926) fell 4.1% to HK$93.55.

  Currently, the Hang Seng Index stands at 24,700, down 133 points or 0.5%, with main board turnover exceeding HK$87.8 billion. The国企 Index is at 8,238, down 35 points or 0.4%. The Hang Seng Tech Index is at 4,334, down 44 points or 1%. The Biotech Index is at 15,862, down 465 points or 2.85%.
 
Performance of stocks in the same sector or related stocks
Stock (Code)Current Price (HK$)Change (%)
Genscript Biotech (01548)39.82Down 4.65%
WuXi Biologics (02269)51.95Down 1.61%
WuXi AppTec (02359)206.60Down 0.48%
Pharmaron (03759)30.50Down 0.33%
Insilico Medicine (03696)56.45Down 3.75%
XtalPi Holdings (02228)8.145Down 2.86%
XTAL Biotech-P (07666)15.70Down 9.67%
Innovent Biologics (01801)100.30Down 3.00%
BeiGene (06160)214.80Down 1.56%
Akeso (09926)93.55Down 4.05%
China Biologic Products (01177)5.615Down 1.32%
CSPC Pharmaceutical Group (01093)9.435Down 2.23%
Hansoh Pharmaceutical (03692)33.74Down 3.43%
(hc)
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.